J&J Hid Topamax Birth Defect Risks, Philly Jury Hears
A Johnson & Johnson subsidiary failed to adequately warn parents about the risk of birth defects associated with the epilepsy and migraine drug Topamax, an attorney for the family of a...To view the full article, register now.
Already a subscriber? Click here to view full article